Riskpilot← Back to searchSign inGet full accessCell Net Software (CNS) Aktiebolag
ABActiveOrg 5565961611Ljungvägen 9 BComputer programming activities · NACE 6210Est. 20000 employees
Revenue 2025
SEK 0
EBITDA margin
—
-3% vs 2024
Equity ratio
62.2%
Financial strength
Net profit 2025
SEK -51K
-6347% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -325K | -3% |
| Net profit | SEK -51K | -6347% |
| Total assets | SEK 1,8M | -15% |
| Equity | SEK 1,1M | -19% |
| Employees | 0 | — |
Legal name
Cell Net Software (CNS) Aktiebolag
Org number
5565961611
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
5 september 2000
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet inom coaching, data, tele, medicin, cellforskning och informationsteknologi, såsom programutveckling, systemutveckling, projektledning, utbildning, bedriva handel med aktier och andra värdepapper samt dårmed förenlig verksamhet.
Address
Ljungvägen 9 B
Phone
+46704800065
Email
abtin.moniri@cellnetsoftware.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 596 | 1 463 | 1 408 | 563 | 0 |
| Staff expenses | — | −644 | −366 | −400 | 30 |
| EBITDA | 150 | 699 | 600 | −315 | −325 |
| Depreciation & amort. | −10 | −10 | — | — | — |
| EBIT | 140 | 689 | 600 | −315 | −325 |
| Net financials | — | 103 | 46 | 67 | 191 |
| Profit before tax | 216 | 610 | 595 | 4 | −51 |
| Tax | −54 | −112 | −127 | −3 | — |
| Net profit | 162 | 498 | 468 | 1 | −51 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 198 | 2 465 | 2 636 | 2 127 | 1 802 |
| Equity | 1 012 | 1 317 | 1 590 | 1 382 | 1 121 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 460 | 241 | 89 | 40 | 59 |
| Total debt | 460 | 241 | 89 | 40 | 59 |
EBITDA margin
-32502200.0%
This company
15.8%
Market median
-205710227% vs market
20212025
Equity ratio
62.2%
This company
38.2%
Market median
+63% vs market
20212025
Return on equity
-4.5%
This company
18.4%
Market median
-124% vs market
20212025
Net profit margin
-5078700.0%
This company
8.1%
Market median
-62700100% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AB Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
AM Chief Executive Officer | Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cell Net Software (CNS) Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Armin Bidarian Moniri | Deputy Chief Executive Officer | 0 companies |
| Abtin Moniri | Chief Executive Officer | 0 companies |